Screener
Amylyx Pharmaceuticals, Inc. AMLX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s total assets?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported total assets of $264.56M in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s total assets changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s total assets increased by 36.0% year-over-year, from $194.6M to $264.56M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s total assets?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s total assets has grown at a 33.2% compound annual growth rate (CAGR), from $105.61M to $332.65M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude